Shuttle Pharmaceuticals Holdings, Inc.
NasdaqCM · USDShuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.
Be the first to share your outlook and start the conversation with other investors in the SHPH community.